Ocean Bio-Chem Inc
NASDAQ:OBCI
Balance Sheet
Balance Sheet Decomposition
Ocean Bio-Chem Inc
Current Assets | 42.9m |
Cash & Short-Term Investments | 10.2m |
Receivables | 11.1m |
Other Current Assets | 21.6m |
Non-Current Assets | 19.1m |
PP&E | 17.8m |
Intangibles | 1.3m |
Current Liabilities | 5.5m |
Accounts Payable | 3.4m |
Accrued Liabilities | 1.2m |
Other Current Liabilities | 952.1k |
Non-Current Liabilities | 8m |
Long-Term Debt | 7.5m |
Other Non-Current Liabilities | 523.1k |
Balance Sheet
Ocean Bio-Chem Inc
Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
2
|
3
|
3
|
2
|
4
|
2
|
1
|
6
|
11
|
13
|
|
Cash |
2
|
3
|
3
|
2
|
4
|
2
|
1
|
6
|
11
|
13
|
|
Total Receivables |
3
|
5
|
6
|
6
|
6
|
7
|
7
|
8
|
10
|
11
|
|
Accounts Receivables |
3
|
4
|
5
|
5
|
5
|
5
|
6
|
7
|
8
|
10
|
|
Other Receivables |
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
|
Inventory |
9
|
7
|
8
|
8
|
9
|
9
|
12
|
10
|
13
|
17
|
|
Other Current Assets |
1
|
1
|
1
|
1
|
1
|
4
|
3
|
3
|
2
|
2
|
|
Total Current Assets |
15
|
16
|
18
|
17
|
20
|
22
|
24
|
27
|
36
|
42
|
|
PP&E Net |
5
|
5
|
5
|
5
|
5
|
9
|
10
|
10
|
10
|
17
|
|
PP&E Gross |
5
|
5
|
0
|
0
|
0
|
0
|
0
|
10
|
10
|
17
|
|
Accumulated Depreciation |
9
|
9
|
0
|
0
|
0
|
0
|
0
|
14
|
15
|
16
|
|
Intangible Assets |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
1
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Assets |
21
N/A
|
22
+6%
|
24
+8%
|
24
-1%
|
26
+8%
|
32
+25%
|
35
+10%
|
38
+9%
|
48
+25%
|
60
+26%
|
|
Liabilities | |||||||||||
Accounts Payable |
1
|
1
|
1
|
1
|
2
|
2
|
1
|
1
|
2
|
3
|
|
Accrued Liabilities |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Liabilities |
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
4
|
5
|
|
Long-Term Debt |
2
|
1
|
1
|
0
|
0
|
4
|
5
|
4
|
4
|
8
|
|
Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Liabilities |
5
N/A
|
4
-13%
|
4
-6%
|
3
-18%
|
3
-2%
|
7
+124%
|
8
+10%
|
8
-3%
|
8
+6%
|
13
+61%
|
|
Equity | |||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
8
|
9
|
11
|
12
|
13
|
15
|
17
|
20
|
29
|
37
|
|
Additional Paid In Capital |
9
|
9
|
9
|
9
|
10
|
10
|
10
|
11
|
11
|
11
|
|
Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
16
N/A
|
18
+11%
|
20
+11%
|
21
+3%
|
23
+9%
|
25
+11%
|
27
+10%
|
31
+12%
|
40
+30%
|
47
+19%
|
|
Total Liabilities & Equity |
21
N/A
|
22
+6%
|
24
+8%
|
24
-1%
|
26
+8%
|
32
+25%
|
35
+10%
|
38
+9%
|
48
+25%
|
60
+26%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
8
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
10
|